Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Opitz

Showing results (221-230 of 253) with videos related to

Pageof 26
Sort By:
The Annals of Thoracic Surgery|April 22, 2026
The Society of Thoracic Surgeons 2026 Expert Consensus on the Multimodal Treatment of Pleural MesotheliomaJeffrey B Velotta, Anja C Roden, Jonathan Rice, et al.
Molecular Oncology|October 12, 2022
Heterogeneous RNA editing and influence of ADAR2 on mesothelioma chemoresistance and the tumor microenvironmentAnanya Hariharan, Weihong Qi, Hubert Rehrauer, et al.
Plos Genetics|December 20, 2015
Combined Genetic and Genealogic Studies Uncover a Large BAP1 Cancer Syndrome Kindred Tracing Back Nine Generations to a Common Ancestor from the 1700sMichele Carbone, Erin G Flores, Mitsuru Emi, et al.
The European Respiratory Journal|October 13, 2022
ERS/ESTS statement on the management of pleural infection in adultsEihab O Bedawi, Sara Ricciardi, Maged Hassan, et al.
The Annals of Thoracic Surgery|January 11, 2025
The Society of Thoracic Surgeons (STS) Clinical Practice Guideline on Surgical Management of Oligometastatic Non-small Cell Lung CancerMara B Antonoff, Kyle G Mitchell, Samuel S Kim, et al.
The Lancet. Oncology|November 6, 2015
Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trialRolf A Stahel, Oliver Riesterer, Alexandros Xyrafas, et al.
Acta Neuropathologica|August 18, 2021
Correction to: Single‑cell profiling of myasthenia gravis identifies a pathogenic T cell signatureFlorian Ingelfinger, Sinduya Krishnarajah, Michael Kramer, et al.
Acta Neuropathologica|March 28, 2021
Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signatureFlorian Ingelfinger, Sinduya Krishnarajah, Michael Kramer, et al.
Translational Lung Cancer Research|May 20, 2021
Stage III N2 non-small cell lung cancer treatment: decision-making among surgeons and radiation oncologistsMarkus Glatzer, Pawel Leskow, Francesca Caparrotti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2026
Metastatic Trajectories in Non-Small Cell Lung Cancer Guide Local and Systemic TherapiesJonas Willmann, Edward Christopher Dee, Lizza E L Hendriks, et al.
Pageof 26

Showing results (221-230 of 253) with videos related to

Sort By:
Pageof 26
The Annals of Thoracic Surgery|April 22, 2026
The Society of Thoracic Surgeons 2026 Expert Consensus on the Multimodal Treatment of Pleural MesotheliomaJeffrey B Velotta, Anja C Roden, Jonathan Rice, et al.
Molecular Oncology|October 12, 2022
Heterogeneous RNA editing and influence of ADAR2 on mesothelioma chemoresistance and the tumor microenvironmentAnanya Hariharan, Weihong Qi, Hubert Rehrauer, et al.
Plos Genetics|December 20, 2015
Combined Genetic and Genealogic Studies Uncover a Large BAP1 Cancer Syndrome Kindred Tracing Back Nine Generations to a Common Ancestor from the 1700sMichele Carbone, Erin G Flores, Mitsuru Emi, et al.
The European Respiratory Journal|October 13, 2022
ERS/ESTS statement on the management of pleural infection in adultsEihab O Bedawi, Sara Ricciardi, Maged Hassan, et al.
The Annals of Thoracic Surgery|January 11, 2025
The Society of Thoracic Surgeons (STS) Clinical Practice Guideline on Surgical Management of Oligometastatic Non-small Cell Lung CancerMara B Antonoff, Kyle G Mitchell, Samuel S Kim, et al.
The Lancet. Oncology|November 6, 2015
Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trialRolf A Stahel, Oliver Riesterer, Alexandros Xyrafas, et al.
Acta Neuropathologica|August 18, 2021
Correction to: Single‑cell profiling of myasthenia gravis identifies a pathogenic T cell signatureFlorian Ingelfinger, Sinduya Krishnarajah, Michael Kramer, et al.
Acta Neuropathologica|March 28, 2021
Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signatureFlorian Ingelfinger, Sinduya Krishnarajah, Michael Kramer, et al.
Translational Lung Cancer Research|May 20, 2021
Stage III N2 non-small cell lung cancer treatment: decision-making among surgeons and radiation oncologistsMarkus Glatzer, Pawel Leskow, Francesca Caparrotti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2026
Metastatic Trajectories in Non-Small Cell Lung Cancer Guide Local and Systemic TherapiesJonas Willmann, Edward Christopher Dee, Lizza E L Hendriks, et al.
Pageof 26